Papua New Guinea vs Yemen: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Papua New Guinea
44.0%
in 2025
Yemen
39.0%
in 2025
Papua New Guinea rank
159th
Yemen rank
160th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Papua New Guinea
- Yemen
How they compare
Papua New Guinea currently reports 44.0% against 39.0% in Yemen, a difference of 5.0%.
That makes Papua New Guinea's figure about 1.1 times Yemen's.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Yemen ahead.
Papua New Guinea ranks 159th and Yemen ranks 160th of 194 countries.
Yemen has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Papua New Guinea | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 14.6% | 54.0% | 39.4% | Yemen |
| 2020s | 37.8% | 48.7% | 10.8% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Papua New Guinea or Yemen?
- Papua New Guinea, at 44.0% against 39.0% in Yemen as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Papua New Guinea and Yemen?
- 5.0%, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and Yemen?
- 18 years are reported by both, from 2008 to 2025.
- How do Papua New Guinea and Yemen rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Papua New Guinea ranks 159th and Yemen ranks 160th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.